The Department of Defense recognizes third-party supplement certification, including the BSCG program, as a measure to mitigate the risk of inadvertent BPC-157 exposure
If you feel unusually fatigued, breathless, or run-down beyond what reduced calories would explain, low iron is worth ruling out with your clinician rather than self-treating, since too much iron carries its own risks
These require immediate surgeon and PlexusDx clinician notification
About the GEMINI-1 Clinical Trial The GEMINI-1 clinical trial was a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study (NCT06396429) conducted by Hengrui in China to evaluate the efficacy and safety of HRS9531 injection in adults (18 years of age) with obesity (BMI 28 kg/m 2 ) or overweight (BMI 24 kg/m 2 ) and at least one weight-related comorbidity without diabetes
Skin texture improves, surface irregularities flatten, and pigment begins to normalize